Cargando…
Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E(−/−) mice
BACKGROUND: There is strong evidence indicating that gut microbiota have the potential to modify, or be modified by the drugs and nutritional interventions that we rely upon. This study aims to characterize the compositional and functional effects of several nutritional, neutraceutical, and pharmace...
Autores principales: | Ryan, Paul M., London, Lis E. E., Bjorndahl, Trent C., Mandal, Rupasri, Murphy, Kiera, Fitzgerald, Gerald F., Shanahan, Fergus, Ross, R. Paul, Wishart, David S., Caplice, Noel M., Stanton, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346842/ https://www.ncbi.nlm.nih.gov/pubmed/28285599 http://dx.doi.org/10.1186/s40168-017-0246-x |
Ejemplares similares
-
Genome Sequence of the Heteropolysaccharide-Producing Strain Lactobacillus mucosae DPC 6426
por: Ryan, Paul M., et al.
Publicado: (2015) -
Correction: Accurate, Fully-Automated NMR Spectral Profiling for Metabolomics
por: Ravanbakhsh, Siamak, et al.
Publicado: (2015) -
Exploring the Gut Microbiota and Cardiovascular Disease
por: Murphy, Kiera, et al.
Publicado: (2021) -
Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
por: Zordoky, Beshay N., et al.
Publicado: (2015) -
Cancer Metabolomics and the Human Metabolome Database
por: Wishart, David S., et al.
Publicado: (2016)